Lakefront Biotherapeutics NV (LKFT) Price Prediction & Forecast

$29.900

-0.030 (-0.10%)At close

Price Predictions

1-Day Price Prediction

+0.56%

1-Week Prediction

+1.02%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

Open in app to unlock longer-horizon forecasts.

Loading chart…

LKFT Prediction & Forecast by Similar Chart Analysis

Alphio's LKFT stock price prediction model matches the current Lakefront Biotherapeutics NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $30.07 (+0.56%). The 1-week path is $30.20 (+1.02%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Lakefront Biotherapeutics NV Stock?

Lakefront Biotherapeutics appears to be a good buy right now due to its current price of $29.90, which is below the analyst price target of $45 set by RBC Capital, indicating significant upside potential. Additionally, the stock has a low P/E ratio of 3.29, suggesting it is undervalued compared to its earnings. However, the main risk is the forward P/E of 344.83, indicating potential volatility in future earnings expectations.